Blood markers in people with acne
Part of Skin clinical trials.
This study is looking at two substances in the blood (CXCL10 and CRP) that may be linked to how severe acne is. By measuring these levels, the study hopes to understand acne better and possibly find new ways to measure or treat it.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 12 and 40 years old.
- You have been diagnosed with acne, whether mild, moderate, or severe.
- You are not currently taking oral acne medication (like isotretinoin or antibiotics) or anti-inflammatory drugs.
- You do not have other conditions that cause inflammation, such as autoimmune diseases, infections, or chronic illnesses.
- You are not pregnant or breastfeeding.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at whether there is a link between acne and cholesterol levels in young adults. If you have acne, joining could help doctors understand more about acne and how it relates to blood fats (lipids).
This study looks at whether certain fats in the blood (called ceramides and sphingosine-1-phosphate) are different in people with acne compared to those without. It may help doctors understand acne better and could lead to new ways to treat it in the future.
This study tests whether balancing the skin's natural bacteria (microbiome) can be a new way to treat acne. If you have mild to moderate facial acne that keeps coming back, this trial may help find a better treatment.
This trial measures a blood protein called catestatin in people with moderate to severe acne. It aims to understand how catestatin relates to acne, which may help guide future treatments.
This trial studies whether putting antibiotic creams on mild-to-moderate facial acne reduces inflammation. It may help answer whether topical erythromycin or clindamycin can improve acne-related redness and swelling.
This study looks at how the bacteria on your face change when you take a medicine called isotretinoin for acne. It might help doctors understand why the medicine works and how to improve acne treatment.
Hear when a new Acne Vulgaris trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.